NDC 70518-3398-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3398
- Requested NDC
- 70518-3398-01
- Package NDCs from labels
- 70518-3398-0, 70518-3398-1, 70518-3398-2, 70518-3398-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3398-0 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | 6 | |
| 70518-3398-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | 6 | |
| 70518-3398-2 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3398 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [REMEDYREPACK INC.] | 4 | Current NDC, Legacy NDC, 3 package rows | 20241004_fd07d24c-6db1-4f6b-b226-68abba3a3321.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CoTZ Silky Foam Non-Tinted | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 9c04b76e-ae65-4183-b475-3b8e8764db59 | 2025-01-24 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Redpharm drug | fa1c0b92-4360-bcfd-e053-6394a90a955a | 2025-01-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| DOCTRUST K Tooth | SILICON DIOXIDE, SODIUM MONOFLUOROPHOSPHATE | DOCSMEDI Co., Ltd. | a02f8865-e7be-4ef4-b09c-dad846639764 | 2025-01-22 | Warnings | ETJ7Z6XBU4 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Direct_Rx | 05156717-fe1b-22f1-e063-6394a90a3d10 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lemon Quince | LEMON QUINCE | Uriel Pharmacy Inc | 332e4a40-e0f3-11de-8a39-0800200c9a66 | 2025-01-22 | Warnings | ETJ7Z6XBU4 |
| METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Ajanta Pharma USA Inc. | 8b78d7ad-22a8-4a9f-afb5-d18f0a4e6d36 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d8284747-07b6-9775-e053-2a95a90ad52d | 2025-01-21 | Warnings, Adverse reactions | ANDA204901 979468 3ST302B24A 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d88ad738-a915-7679-e053-2a95a90a58c7 | 2025-01-21 | Warnings, Adverse reactions | ANDA204901 979471 3ST302B24A 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 93f6a018-8b3d-4f40-be25-902daec19aea | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | DIRECT RX | cbe5e01e-67ca-f8a2-e053-2995a90a0d15 | 2025-01-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | cf4278a3-fbb7-a8ab-e053-2a95a90abc0f | 2025-01-20 | Warnings, Adverse reactions | 979471 3ST302B24A 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d1ed9593-a587-55bb-e053-2995a90a8a9a | 2025-01-20 | Warnings, Adverse reactions | 979471 3ST302B24A 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d1ee193e-bf78-3134-e053-2a95a90a65d2 | 2025-01-20 | Warnings, Adverse reactions | 979464 3ST302B24A 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d2021060-94d7-3e1d-e053-2995a90a10ee | 2025-01-20 | Warnings, Adverse reactions | 979468 3ST302B24A 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | DirectRx | d358499d-5ebb-75b2-e053-2a95a90a4223 | 2025-01-20 | Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Direct_Rx | e9aa536e-0747-45bf-e053-2995a90ae7d6 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | DIRECT RX | a5b5da65-a4d5-1bd5-e053-2a95a90a6a60 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | DIRECT RX | a58c56b2-e05c-6697-e053-2a95a90ad466 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Proceuticals Private Label by TiZO Tinted Facial Mineral Sunscreen Backbar | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 2be9f92a-a041-0595-e063-6394a90af7a8 | 2025-01-17 | Warnings | 15FIX9V2JP |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct_Rx | 8de04bf2-83dd-c494-e053-2a95a90abade | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 979468 979471 979464 3ST302B24A 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.